Ankylosing spondylitis patients with and without psoriasis do not differ in disease phenotype

Annals of the Rheumatic Diseases

Volumn 72, Issue 6, 2013, Pages 1104-1107

  Machado, Pedro ^a,b   Landewé, Robert ^c,d   Braun, Jürgen ^e   Baraliakos, Xenofon ^e   Hermann, Kay Geert A ^f   Hsu, Benjamin ^g   Baker, Daniel ^g   Van Der Heijde, Désirée ^a  

^a LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^b CENTRO HOSPITALAR E UNIVERSITÁRIO DE COIMBRA   (Portugal)

^c ACADEMIC MEDICAL CENTER   (Netherlands)

^d Zuyderland Medical Centre   (Netherlands)

^e RheumazentrumRuhrgebiet ^*  (Germany)

^f CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^g CENTOCOR INC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

INFLIXIMAB;

ANKYLOSING SPONDYLITIS; BATH ANKYLOSING SPONDYLITIS DISEASE ACTIVITY INDEX; CLINICAL FEATURE; DIAGNOSTIC IMAGING; DISEASE ACTIVITY; DISEASE ASSOCIATION; HUMAN; JOINT SWELLING; LETTER; PAIN ASSESSMENT; PHYSICAL CAPACITY; PRIORITY JOURNAL; PSORIASIS; QUALITY OF LIFE; SPINAL PAIN; SPINE MOBILITY;

ANKYLOSING SPONDYLITIS; EPIDEMIOLOGY; OUTCOMES RESEARCH; PSORIATIC ARTHRITIS; SPONDYLOARTHRITIS;

ADULT; COHORT STUDIES; FEMALE; HUMANS; MALE; MIDDLE AGED; PSORIASIS; SPONDYLITIS, ANKYLOSING;

EID: 84877635035     PISSN: 00034967     EISSN: 14682060     Source Type: Journal    
DOI: 10.1136/annrheumdis-2012-202922     Document Type: Letter

References (10)

1. Rudwaleit M, van der Heijde D, Landewe R, et al. The Assessment of SpondyloArthritis International Society classification criteria for peripheral spondyloarthritis and for spondyloarthritis in general. Ann Rheum Dis 2011;70:25-31.
2. Chandran V, Barrett J, Schentag CT, et al. Axial psoriatic arthritis: update on a longterm prospective study. J Rheumatol 2009;36:2744-50.
3. Gladman DD. Axial disease in psoriatic arthritis. Curr Rheumatol Rep 2007;9:455-60. (Pubitemid 350305202)
4. Richette P, Tubach F, Breban M, et al. Psoriasis and phenotype of patients with early infl ammatory back pain. Ann Rheum Dis 2012; epub ahead of print.
5. Perez Alamino R, Maldonado Cocco JA, Citera G, et al. Differential features between primary ankylosing spondylitis and spondylitis associated with psoriasis and inflammatory bowel disease. J Rheumatol 2011;38:1656-60.
6. Fernandez-Sueiro JL, Willisch A, Pertega-Diaz S, et al. Evaluation of ankylosing spondylitis spinal mobility measurements in the assessment of spinal involvement in psoriatic arthritis. Arthritis Rheum 2009;61:386-92.
7. Edmunds L, Elswood J, Kennedy LG, et al . Primary ankylosing spondylitis, psoriatic and enteropathic spondyloarthropathy: a controlled analysis. J Rheumatol 1991;18:696-8.
8. Taylor WJ, Harrison AA. Could the Bath Ankylosing Spondylitis Disease Activity Index (BASDAI) be a valid measure of disease activity in patients with psoriatic arthritis? Arthritis Rheum 2004;51:311-15. (Pubitemid 38725126)
9. Helliwell PS, Hickling P, Wright V. Do the radiological changes of classic ankylosing spondylitis differ from the changes found in the spondylitis associated with inflammatory bowel disease, psoriasis, and reactive arthritis? Ann Rheum Dis 1998;57:135-40.
10. van der Heijde D, Dijkmans B, Geusens P, et al. Efficacy and safety of infliximab in patients with ankylosing spondylitis: results of a randomized, placebo-controlled trial (ASSERT). Arthritis Rheum 2005;52:582-91. (Pubitemid 40216323)